In this study, we reveal that ANXA7 enhances a dynein-driven RNP transport mechanism related with the degradation of these RNPs, thereby counteracting TIA1 aggregation in axons and providing a potential strategy to target and eliminate pathogenic aggregates underlying neurodegenerative diseases. Here, RNPC3 is linked to neurodegenerative disease.